{"id":"W3203242711","doi":"10.1007/s00259-021-05564-0","title":"Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms","year":2021,"lang":"en","type":"article","venue":"European Journal of Nuclear Medicine and Molecular Imaging","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"European Commission; Swiss Cancer Research Foundation; Neuroendocrine Tumor Research Foundation","keywords":"DOTA; Somatostatin receptor; In vivo; Medicine; Cancer research; Viability assay; Neuroendocrine tumors; Radionuclide therapy; Somatostatin receptor 2; Somatostatin; Terbium; Pharmacology; In vitro; Chemistry; Nuclear medicine; Internal medicine; Biochemistry; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001828552,0.0001549001,0.0004185088,0.0001389029,0.00006963458,0.00001693946,0.0001054651,0.000001692535,0.00003194236],"category_scores_gemma":[0.0001845408,0.0000915576,0.0001136373,0.0001506558,0.0002951796,0.00008426839,0.00003081322,0.0001416766,7.652554e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001869535,"about_ca_system_score_gemma":0.00007390563,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007203159,"about_ca_topic_score_gemma":5.383393e-7,"domain_scores_codex":[0.9984894,0.0002166871,0.0005055657,0.0001657932,0.0004162388,0.0002062878],"domain_scores_gemma":[0.9988607,0.000144515,0.0003953723,0.0002174224,0.0002349721,0.0001470579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005153013,0.001479842,0.00406669,0.000771474,0.0008036779,0.07154066,0.002404962,0.00006686273,0.8713425,0.001376697,0.005760885,0.0352327],"study_design_scores_gemma":[0.06349741,0.04937373,0.02082721,0.002799379,0.002584029,0.08873222,0.008977118,0.001826968,0.3623498,0.0004037714,0.39807,0.000558398],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9230664,0.003918504,0.002331949,0.06968988,0.0002001324,0.0004408325,0.00001094143,0.00001304661,0.000328262],"genre_scores_gemma":[0.9949637,0.001804896,0.002190975,0.0008487912,0.000104814,0.000001166602,0.000008474132,0.00005531815,0.00002183799],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5089928,"threshold_uncertainty_score":0.3733611,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0126837470383656,"score_gpt":0.2794334801016644,"score_spread":0.2667497330632987,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}